Concepedia

Siva Sai Krishna Dasa

SS

Statistics

Publications

11

Citations

312

H-Index

10

Active since

2007

Affiliations

University of Virginia(Current)

AstraZeneca (Sweden)

Argonne National Laboratory

Frederick National Laboratory for Cancer Research

Teikyo University

Siva Sai Krishna Dasa is an author at University of Virginia specializing in nanomedicine, engineering, and small molecules.

ORCID

Top concepts

Publications per year

2007–2021

11

Publications

11

Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer

Siva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki et al. · Theranostics · 2018 · 72 citations · Full text

Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction

Siva Sai Krishna Dasa, Ryo Suzuki, Michael Gutknecht et al. · Journal of Controlled Release · 2015 · 65 citations · Full text

, , +11

PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing

Lindsey T. Brinton, Dustin K. Bauknight, Siva Sai Krishna Dasa et al. · PLoS ONE · 2016 · 44 citations · Full text

Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging

Zibo Li, Qiaoling Jin, Chiun‐Wei Huang et al. · Theranostics · 2011 · 32 citations · Full text

<i>In vivo</i> liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects

Victoria Osinski, Dustin K. Bauknight, Siva Sai Krishna Dasa et al. · Theranostics · 2019 · 22 citations · Full text

1–5 of 11